ASH successes set to lift Imbruvica in CLL

ASH successes set to lift Imbruvica in CLL

Source: 
Biopharma Dive
snippet: 

Positive data from three studies might be a commercial boon for AbbVie and J&J's drug. Yet high expectations could leave room for investor disappointment.